AVITA Medical Stock (NASDAQ: RCEL) stock price, news, charts, stock research, profile.
You can purchase shares of AVITA Medical (NASDAQ:RCEL) through any online brokerage.
Other companies in AVITA Medical’s space includes: Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR) and Tevogen Bio Holdings (NASDAQ:TVGN).
AVITA Medical has a consensus price target of $19.80.
The stock price for AVITA Medical (NASDAQ: RCEL) is $9.32 last updated January 24, 2025 at 4:00 PM EST.
There are no upcoming dividends for AVITA Medical.
AVITA Medical’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for AVITA Medical.
AVITA Medical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.